Quest Diagnostics
837 hedge funds and large institutions have $13.3B invested in Quest Diagnostics in 2024 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 277 increasing their positions, 300 reducing their positions, and 59 closing their positions.
131% more call options, than puts
Call options by funds: $92.2M | Put options by funds: $39.9M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
53% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 59
2% more funds holding
Funds holding: 818 → 837 (+19)
1% more capital invested
Capital invested by funds: $13.2B → $13.3B (+$134M)
8% less repeat investments, than reductions
Existing positions increased: 277 | Existing positions reduced: 300
2.03% less ownership
Funds ownership: 89.74% → 87.71% (-2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$139M |
| 2 |
Millennium Management
New York
|
+$109M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$89.2M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$53.8M |
| 5 |
VLKIM
Van Lanschot Kempen Investment Management
Amsterdam,
Netherlands
|
+$48.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$140M |
| 2 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$90.7M |
| 3 |
Bessemer Group
Woodbridge,
New Jersey
|
-$90.2M |
| 4 |
BlackRock
New York
|
-$87.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$54.4M |
DGX Hedge Fund Activity: Q2 2024 in Review
837 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2024, worth a combined $13.3B — up 1% from $13.2B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new DGX positions and 59 closed out — a net gain of 31 holders — while 277 added to existing stakes and 300 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $139M. The largest seller was American Century Companies, cutting an estimated $140M.
- 837 institutional investors held Quest Diagnostics (DGX) as of Q2 2024, up from 818 in Q1 2024.
- Funds reported $13.3B of Quest Diagnostics stock for Q2 2024, up 1% quarter-over-quarter.
- 90 funds opened new Quest Diagnostics positions in Q2 2024 and 59 closed out, a net change of +31 holders.
- The largest Quest Diagnostics buyer in Q2 2024 was Citadel Advisors, an estimated $139M added.
- The largest Quest Diagnostics seller in Q2 2024 was American Century Companies, an estimated $140M sold.
Based on aggregated 13F filings for Q2 2024.